/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

F

Fumiki Yoshihara

National Cerebral and Cardiovascular Center(JP)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

213

Papers

5.5K

Citations

40

h-index

94

i10-index

Fumiki Yoshihara is an academic researcher from National Cerebral and Cardiovascular Center. The author has contributed to research in topics: Neuropeptides and Animal Physiology & Blood Pressure and Hypertension Studies & Receptor Mechanisms and Signaling. The author has an h-index of 40, co-authored 182 publications.

ORCID: 0000-0001-9394-4315

Research Topics

Neuropeptides and Animal Physiology Blood Pressure and Hypertension Studies Receptor Mechanisms and Signaling Heart Failure Treatment and Management Hormonal Regulation and Hypertension

Papers by this author

works

Relationship Between Left Ventricular Geometry and Natriuretic Peptide Levels in Essential Hypertension

1996 · Hypertension · 261 citations

https://doi.org/10.1161/01.hyp.28.1.22

Toshio Nishikimi Fumiki Yoshihara Atsushi Morimoto Kazuhiko Ishikawa

Hamiltonian of a flux qubit-LC oscillator circuit in the deep–strong-coupling regime

2022 · Scientific Reports · 19 citations

https://doi.org/10.1038/s41598-022-10203-1

Fumiki Yoshihara Sahel Ashhab T. Fuse Motoaki Bamba

Effects of sodium-glucose co-transporter 2 inhibitors on ultrafiltration in patients with peritoneal dialysis: a protocol for a randomized, double-blind, placebo-controlled, crossover trial (EMPOWERED)

2024 · Clinical and Experimental Nephrology · 11 citations

https://doi.org/10.1007/s10157-024-02467-w

Yohei Doi Maki Shinzawa Tetsuya Arisato Hideaki Oka

DAPagliflozin for the attenuation of albuminuria in Patients with hEaRt failure and type 2 diabetes (DAPPER study): a multicentre, randomised, open-label, parallel-group, standard treatment-controlled trial

2023 · EClinicalMedicine · 6 citations

https://doi.org/10.1016/j.eclinm.2023.102334

Fumiki Yoshihara Miki Imazu Ichiro Sakuma Yukio Hiroi

DAPagliflozin for the attenuation of albuminuria in Patients with hEaRt failure and type 2 diabetes (DAPPER study): a multicentre, randomised, open-label, parallel-group, standard treatment-controlled trial

2023 · EClinicalMedicine · 6 citations

https://doi.org/10.1016/j.eclinm.2023.102334

Fumiki Yoshihara Miki Imazu Ichiro Sakuma Yukio Hiroi

Spectral properties of two superconducting artificial atoms coupled to a resonator in the ultrastrong coupling regime

2025 · Nature Communications · 4 citations

https://doi.org/10.1038/s41467-025-60589-5

Akiyoshi Tomonaga Roberto Stassi Hiroto Mukai Franco Nori

Research topics

topics

Neuropeptides and Animal Physiology

Blood Pressure and Hypertension Studies

Receptor Mechanisms and Signaling

Heart Failure Treatment and Management

Hormonal Regulation and Hypertension

Chat about Author

Papers

Chat

Click to start Chat